Firm profile

Novaquest Capital Management, L.L.C.

CRD 160359Registration Status: ApprovedEffective since March 30, 2012SEC # 801-73992Latest ADV March 31, 2026

Novaquest Capital Management, L.L.C. is an SEC registered investment adviser organized as a limited liability company. Its latest Form ADV filing, dated March 31, 2026, reports $1.5B in regulatory assets under management, 18 employees, and 14 accounts.

Assets Under Management
$1.5B
Employees
18
Offices
--
Total Clients
14

Associated firm names

1 name listed
  • NOVAQUEST CAPITAL MANAGEMENT, L.L.C.

Leadership

3 roles identified
CCODevin W. Holden
CFORobert W. Hester
CIOMichael J. Bologna

Advisory services offered

1 types reported
Portfolio management for pooled investment vehicles

Fee models offered

2 types reported
Asset based fees
Performance-based fees

Offices & Contact

Primary office

Not reported

Additional office locations have not been imported yet.

Contact and digital presence

ADV profile links

Regulatory Assets Under Management Breakdown

Total regulatory assets under management$1.5Bas of March 31, 2026
Discretionary100.0%
$1.5B
100% of total RAUM100.0%
Non-discretionary0.0%
$0
0% of total RAUM0.0%
All regulatory assets under management are discretionary.

Client Coverage Demographics

Top client segmentPooled Investment Vehicles represent 100.0% of total clients.
Top client categories% of clientsClients
1
Pooled Investment Vehicles
100.0%
14

Assets under management Growth by Quarter

Quarterly points use the latest ADV filing or SEC roster snapshot available in each quarter.

Total AUM$1.5B
Total Accounts14
10Y AUM Change+$12M (+0.8%)

Private Funds

Private funds reported by Novaquest Capital Management, L.L.C.

Loading private fund disclosures…

Employee Growth by Quarter

Quarterly points use the latest ADV filing or SEC roster snapshot available in each quarter.

Total Employees18
Clients per Employee1:1
10Y Employee Change+2 (+12.5%)

Historical AUM and employee figures reflect available SEC Form ADV filings under this CRD. Filing gaps may reflect registration status changes, dormant periods, state registration periods, firm restructuring, or other reporting changes. Rialytix does not interpolate missing periods.


Ownership

Reported direct and indirect ownership ranges

Each range applies to a separate reported relationship and should not be added together.

Reported ownership ranges

Highlighted bands show the percentage range reported in Form ADV.

0%25%50%75%100%
PHARMABIO DEVELOPMENT INC.Direct owner · Schedule AInterest in NOVAQUEST CAPITAL MANAGEMENT, L.L.C.
50% to < 75%
MBK PHARMAPARTNERING, INC.Direct owner · Schedule AInterest in NOVAQUEST CAPITAL MANAGEMENT, L.L.C.
10% to < 25%
ROBERT WAYNE HESTERDirect owner · Schedule AInterest in NOVAQUEST CAPITAL MANAGEMENT, L.L.C.
< 5%
ERNEST GERALD BROWNDirect owner · Schedule AInterest in NOVAQUEST CAPITAL MANAGEMENT, L.L.C.
< 5%
Bryan Edwards MillsDirect owner · Schedule AInterest in NOVAQUEST CAPITAL MANAGEMENT, L.L.C.
< 5%
PATRICK BROOKS JORDANDirect owner · Schedule AInterest in NOVAQUEST CAPITAL MANAGEMENT, L.L.C.
< 5%
MICHAEL JAMES BOLOGNADirect owner · Schedule AInterest in NOVAQUEST CAPITAL MANAGEMENT, L.L.C.
< 5%
YOSHITAKA NMN OSHIBADirect owner · Schedule AInterest in NOVAQUEST CAPITAL MANAGEMENT, L.L.C.
< 5%
DENNIS BARRY GILLINGSIndirect owner · Schedule BInterest in GF MANAGEMENT HOLDINGS INC.
75%+
MITSUI & CO., LTD.Indirect owner · Schedule BInterest in MBK PHARMAPARTNERING, INC.
75%+
GF MANAGEMENT HOLDINGS INC.Indirect owner · Schedule BInterest in PHARMABIO DEVELOPMENT INC.
75%+
MIREILLE NMN GILLINGSIndirect owner · Schedule BInterest in GF MANAGEMENT HOLDINGS INC.
25% to < 50%

Bars represent the reported range at that individual ownership step, not an estimated percentage of the advisory firm. Indirect relationships may refer to intermediate entities rather than directly to Novaquest Capital Management, L.L.C..

Reported ownership and control details

Form ADV · Filing date 2026-03-31 · Schedules A and B

13 entries
#Owner / person & roleInterest in entityReported interestControl personTitle / status acquiredSource
1PHARMABIO DEVELOPMENT INC.MEMBERDomestic entityNOVAQUEST CAPITAL MANAGEMENT, L.L.C.50% to less than 75%Code DYesMEMBER11/2010Schedule APDF page 89
2MBK PHARMAPARTNERING, INC.MEMBERDomestic entityNOVAQUEST CAPITAL MANAGEMENT, L.L.C.10% to less than 25%Code BNoMEMBER11/2010Schedule APDF page 89
3ROBERT WAYNE HESTERMEMBER, CHIEF FINANCIAL OFFICER, EXECUTIVE VICE PRESIDENTIndividualNOVAQUEST CAPITAL MANAGEMENT, L.L.C.Less than 5%Code NAYesMEMBER, CHIEF FINANCIAL OFFICER, EXECUTIVE VICE PRESIDENT11/2010Schedule APDF page 89
4ERNEST GERALD BROWNMANAGEMENT COMMITTEE MEMBERIndividualNOVAQUEST CAPITAL MANAGEMENT, L.L.C.Less than 5%Code NAYesMANAGEMENT COMMITTEE MEMBER11/2010Schedule APDF page 89
5Bryan Edwards MillsMEMBER, CHIEF ADMINISTRATIVE OFFICER, MANAGEMENT COMMITTEE MEMBERIndividualNOVAQUEST CAPITAL MANAGEMENT, L.L.C.Less than 5%Code NAYesMEMBER, CHIEF ADMINISTRATIVE OFFICER, MANAGEMENT COMMITTEE MEMBER01/2020Schedule APDF page 89
6PATRICK BROOKS JORDANMEMBER, MANAGING PARTNER, MANAGEMENT COMMITTEE MEMBERIndividualNOVAQUEST CAPITAL MANAGEMENT, L.L.C.Less than 5%Code NAYesMEMBER, MANAGING PARTNER, MANAGEMENT COMMITTEE MEMBER04/2021Schedule APDF page 89
7MICHAEL JAMES BOLOGNAMEMBER, CHIEF INVESTMENT OFFICER, MANAGEMENT COMMITTEE MEMBERIndividualNOVAQUEST CAPITAL MANAGEMENT, L.L.C.Less than 5%Code NAYesMEMBER, CHIEF INVESTMENT OFFICER, MANAGEMENT COMMITTEE MEMBER07/2023Schedule APDF page 89
8DEVIN WEISS HOLDENCHIEF COMPLIANCE OFFICERIndividualNOVAQUEST CAPITAL MANAGEMENT, L.L.C.Less than 5%Code NANoCHIEF COMPLIANCE OFFICER01/2024Schedule APDF page 89
9YOSHITAKA NMN OSHIBAMANAGEMENT COMMITTEE MEMBERIndividualNOVAQUEST CAPITAL MANAGEMENT, L.L.C.Less than 5%Code NAYesMANAGEMENT COMMITTEE MEMBER08/2024Schedule APDF page 89
10DENNIS BARRY GILLINGSSHAREHOLDERIndividualGF MANAGEMENT HOLDINGS INC.75% or moreCode EYesSHAREHOLDER01/2022Schedule BPDF page 90
11MITSUI & CO., LTD.SHAREHOLDERForeign entityMBK PHARMAPARTNERING, INC.75% or moreCode EYesSHAREHOLDER11/2010Schedule BPDF page 90
12GF MANAGEMENT HOLDINGS INC.SHAREHOLDERDomestic entityPHARMABIO DEVELOPMENT INC.75% or moreCode EYesSHAREHOLDER01/2022Schedule BPDF page 90
13MIREILLE NMN GILLINGSSHAREHOLDERIndividualGF MANAGEMENT HOLDINGS INC.25% to less than 50%Code CYesSHAREHOLDER01/2022Schedule BPDF page 90

Less than 5% may include zero. Code F identifies a role without specifying a percentage. Reported interests may overlap and may not include every owner. Total indirect ownership is not calculated.

Compliance & Disclosures

Filing dated 3/31/2026 9:12:15 PM

Responses were selected by the RIA in its filing. Questions are shortened for readability; “you” refers to the reporting firm, and some questions also cover advisory affiliates.

RIA or supervised-person involvementThe RIA reported that none of the events below involve the firm or its supervised persons.RIA responseNo
AFelonies2 No

In the past ten years, have you or any advisory affiliate:

  • A1Been convicted of or pleaded guilty or no contest to a felony?No
  • A2Been charged with a felony?No
BMisdemeanors2 No

In the past ten years, have you or any advisory affiliate:

  • B1Been convicted of or pleaded guilty or no contest to a misdemeanor involving investments, an investment-related business, fraud, false statements or omissions, wrongful taking of property, bribery, perjury, forgery, counterfeiting, or extortion?No
  • B2Been charged with a misdemeanor of the kind listed above?No
CSEC or CFTC actions5 No

Has the SEC or CFTC ever:

  • C1Found you or an advisory affiliate made a false statement or omission?No
  • C2Found you or an advisory affiliate violated SEC or CFTC regulations or statutes?No
  • C3Found you or an advisory affiliate caused an investment-related business to have its authorization to do business denied, suspended, revoked, or restricted?No
  • C4Entered an order against you or an advisory affiliate in connection with investment-related activity?No
  • C5Imposed a civil money penalty on you or an advisory affiliate, or ordered you or an advisory affiliate to cease and desist from any activity?No
DOther regulatory actions5 No

Has any other federal regulatory agency, state regulatory agency, or foreign financial regulatory authority ever:

  • D1Found you or an advisory affiliate made a false statement or omission, or was dishonest, unfair, or unethical?No
  • D2Found you or an advisory affiliate violated investment-related regulations or statutes?No
  • D3Found you or an advisory affiliate caused an investment-related business to have its authorization to do business denied, suspended, revoked, or restricted?No
  • D4In the past ten years, entered an order against you or an advisory affiliate in connection with investment-related activity?No
  • D5Denied, suspended, or revoked your or an advisory affiliate’s registration or license, or otherwise prevented association with an investment-related business or restricted activities?No
ESelf-regulatory organization actions4 No

Has a self-regulatory organization or commodities exchange ever:

  • E1Found you or an advisory affiliate made a false statement or omission?No
  • E2Found you or an advisory affiliate violated its rules, other than a violation designated as a minor rule violation under an SEC-approved plan?No
  • E3Found you or an advisory affiliate caused an investment-related business to have its authorization to do business denied, suspended, revoked, or restricted?No
  • E4Disciplined you or an advisory affiliate by expulsion, suspension, barring association with other members, or otherwise restricting activities?No
FProfessional authorizations1 No
  • FHas an authorization to act as an attorney, accountant, or federal contractor granted to you or an advisory affiliate ever been revoked or suspended?No
GPending regulatory proceedings1 No
  • GAre you or any advisory affiliate now the subject of a regulatory proceeding that could result in a “Yes” answer to any part of C, D, or E?No
HCivil judicial actions and proceedings4 No

(1) Court actions

Has a domestic or foreign court:

  • H(1)(a)In the past ten years, enjoined you or an advisory affiliate in connection with investment-related activity?No
  • H(1)(b)Found that you or an advisory affiliate violated investment-related statutes or regulations?No
  • H(1)(c)Dismissed, pursuant to a settlement agreement, an investment-related civil action brought against you or an advisory affiliate by a state or foreign financial regulatory authority?No

(2) Pending civil proceedings

  • H(2)Are you or any advisory affiliate now the subject of a civil proceeding that could result in a “Yes” answer to any part of H(1)?No

* Metrics are based on the latest available data, including Form ADV filings, brochures, and relationship summaries pulled from the SEC IAPD, and may be subject to change. Learn what is included in the Rialytix data. Please refer to the firm's official disclosures for the most accurate information using their CRD number. This is not investment advice.